Casdin Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-266,430
| Closed | -$20.2M | – | 50 |
|
|
2021
Q4 | $20.2M | Hold |
266,430
| – | – | 0.57% | 35 |
|
|
2021
Q3 | $29.8M | Hold |
266,430
| – | – | 0.74% | 35 |
|
|
2021
Q2 | $43.1M | Hold |
266,430
| – | – | 1.09% | 27 |
|
|
2021
Q1 | $32.5M | Hold |
266,430
| – | – | 0.97% | 27 |
|
|
2020
Q4 | $40.8M | Hold |
266,430
| – | – | 1.21% | 21 |
|
|
2020
Q3 | $22.3M | Hold |
266,430
| – | – | 1% | 24 |
|
|
2020
Q2 | $19.6M | Hold |
266,430
| – | – | 1.16% | 26 |
|
|
2020
Q1 | $11.3M | Buy |
+266,430
| New | +$11.3M | 1.2% | 24 |
|
|
2018
Q4 | – | Sell |
-220,000
| Closed | -$9.76M | – | 32 |
|
|
2018
Q3 | $9.76M | Hold |
220,000
| – | – | 1.19% | 24 |
|
|
2018
Q2 | $12.9M | Buy |
220,000
+85,000
| +63% | +$4.99M | 1.81% | 19 |
|
|
2018
Q1 | $6.17M | Buy |
+135,000
| New | +$6.17M | 1.09% | 23 |
|